Álvarez-Vázquez, A., San-Segundo, L., Cerveró-García, P., Flores-Hernández, Ollauri‑Ibáñez, C., Segura-Collar, B., . . . Tabernero, A. (2024). EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266–283 antitumor response in preclinical glioblastoma models.
Citación estilo ChicagoÁlvarez-Vázquez, Andrea, et al. EGFR Amplification and EGFRvIII Predict and Participate in TAT-Cx43266–283 Antitumor Response in Preclinical Glioblastoma Models. 2024.
Cita MLAÁlvarez-Vázquez, Andrea, et al. EGFR Amplification and EGFRvIII Predict and Participate in TAT-Cx43266–283 Antitumor Response in Preclinical Glioblastoma Models. 2024.
Precaución: Estas citas no son 100% exactas.